Voya Investment Management LLC Y M Abs Therapeutics, Inc. Transaction History

Voya Investment Management LLC

$85.7 Billion
Q2 2024

A detailed history of Voya Investment Management LLC transactions in Y M Abs Therapeutics, Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 12,601 shares of YMAB stock, worth $161,544. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,601

Previous 12,539 0.49%

Holding current value

$161,544

Previous $203,000 25.12%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$11.6 - $17.25 $719 - $1,069	62 Added 0.49%	12,601 $152,000
Q1 2024 May 15, 2024	SELL	$6.57 - $18.69 $20,143 - $57,303	-3,066 Reduced 19.65%	12,539 $203,000
Q4 2023 Feb 14, 2024	SELL	$4.88 - $7.42 $111,093 - $168,916	-22,765 Reduced 59.33%	15,605 $106,000
Q3 2023 Nov 14, 2023	BUY	$4.86 - $7.23 $19,556 - $29,093	4,024 Added 11.72%	38,370 $209,000
Q2 2023 Aug 14, 2023	SELL	$5.68 - $10.34 $61,872 - $112,633	-10,893 Reduced 24.08%	34,346 $233,000
Q1 2023 May 15, 2023	BUY	$2.83 - $5.11 $21,491 - $38,805	7,594 Added 20.17%	45,239 $226,000
Q4 2022 Feb 14, 2023	BUY	$3.0 - $15.17 $27,579 - $139,457	9,193 Added 32.31%	37,645 $183,000
Q3 2022 Mar 03, 2023	SELL	$13.96 - $19.67 $128,334 - $180,826	-9,193 Reduced 24.42%	28,452 $410,000
Q2 2022 Aug 15, 2022	BUY	$8.22 - $15.13 $5,071 - $9,335	617 Added 2.22%	28,452 $430,000
Q1 2022 May 16, 2022	BUY	$6.55 - $17.42 $92,839 - $246,911	14,174 Added 103.76%	27,835 $331,000
Q4 2021 Feb 14, 2022	SELL	$15.51 - $29.31 $635 - $1,201	-41 Reduced 0.3%	13,661 $221,000
Q2 2021 Aug 16, 2021	SELL	$25.45 - $37.64 $104,166 - $154,060	-4,093 Reduced 23.0%	13,702 $463,000
Q1 2021 May 17, 2021	BUY	$29.16 - $51.96 $45,839 - $81,681	1,572 Added 9.69%	17,795 $538,000
Q4 2020 Feb 16, 2021	BUY	$37.86 - $54.26 $105,212 - $150,788	2,779 Added 20.67%	16,223 $803,000
Q3 2020 Nov 16, 2020	BUY	$35.13 - $43.62 $106,373 - $132,081	3,028 Added 29.07%	13,444 $516,000
Q2 2020 Aug 14, 2020	SELL	$23.66 - $49.53 $32,366 - $67,757	-1,368 Reduced 11.61%	10,416 $450,000
Q1 2020 May 15, 2020	BUY	$14.39 - $35.8 $8,087 - $20,119	562 Added 5.01%	11,784 $308,000
Q4 2019 Feb 14, 2020	BUY	$23.81 - $33.78 $267,195 - $379,079	11,222 New	11,222 $351,000

Others Institutions Holding YMAB

# of Institutions

Shares Held

23.8M

Call Options Held

19.4K

Put Options Held

300

View Full List

About Y-mAbs Therapeutics, Inc.

Ticker YMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,719,500
Market Cap $560M
Description
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...

More about YMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.

Account

Voya Investment Management LLC Y M Abs Therapeutics, Inc. Transaction History